Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Lion Biotechnologies, Inc. (NASDAQ:LBIO) Securities Case

NEW YORK--()--Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, reminds investors that June 13, 2017 is the last day to file lead plaintiff papers in the securities lawsuit against Lion Biotechnologies, Inc. (“Lion” or the “Company”) (NASDAQ: LBIO). The class action is on behalf of a class consisting of all persons who purchased Lion common stock between November 14, 2013 and April 10, 2017, both dates inclusive (the “Class Period”). Lion investors are encouraged to contact Scott+Scott toll free at (844) 818-6982 for more information.

Lion focuses on developing and commercializing cancer immunotherapy products.

The lawsuit alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Lion Biotechnologies, through its former CEO Manish Singh, engaged in a scheme to mislead investors by commissioning over 10 internet publications and 20 widely distributed emails promoting Lion Biotechnologies to potential investors that purported to be independent from the company when, in fact, they were paid promotions; (2) former CEO Singh engaged a stock promotion firm to pay writers to publish articles about Lion Biotechnologies on investment websites as well as to coordinate the distribution of articles to thousands of electronic mailboxes; (3) former CEO Singh actively participated in the promotional work for Lion Biotechnologies and understood that the promotion firm was using writers who would not disclose that Lion Biotechnologies was indirectly compensating them for their publications; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What You Can Do

If you purchased Lion shares, you may have legal claims against the Company. If you want to discuss filing lead plaintiff papers, or have questions about your legal rights, please contact attorney Joseph Pettigrew at (844) 818-6982, or at jpettigrew@scott-scott.com.

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Contacts

Scott+Scott, Attorneys at Law, LLP
Joseph Pettigrew, (844) 818-6982
jpettigrew@scott-scott.com

Release Summary

June 13th is the Last Day to Move to be Lead Plaintiff in the Lion Biotechnologies Securities Class Action - Interested Investors are Encouraged to Contact Scott+Scott

Contacts

Scott+Scott, Attorneys at Law, LLP
Joseph Pettigrew, (844) 818-6982
jpettigrew@scott-scott.com